Specific post-translational modifications of soluble tau protein distinguish between Alzheimer’s disease and primary tauopathies

The Source Data file contains all data which graphs and tables of the manuscript are from : “Specific post-translational modifications of the soluble tau protein distinguish between Alzheimer’s disease and primary tauopathies”. Sheet 1: Uncropped Westernblot results (Fig2) Sheet 2: Absolute quantities of tau 4R and 3R tau isoforms in insoluble (left table) and soluble (right table) used to produce Fig. 3. Sheet 3: Abundances values (extracted ions chromatogram area under the curve) of the tau protein different PTMs, for insoluble (upper table) and soluble brain fractions (bottom panel), that were used to produce Figures 4, 5, 6 and 7. Sheet 4: Subjects characteristics used to produce Table 1. Sheet 5: Wilcoxon test’s p-value scores used to produce Table 2 and Supplementary Table 4.